Using photo-medicine to guide reoperation for lymph nodes in recurrent breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates a dual approach using photo-medicine to guide the reoperation of sentinel lymph nodes in patients with locally recurrent breast cancer. The study aims to improve the identification rate of sentinel lymph nodes, which is crucial for effective staging and treatment planning. Participants will include female patients aged 18 and older who have previously undergone axillary surgery for breast cancer. The trial seeks to clarify the role of sentinel lymph node biopsy in the surgical management of recurrent cases, which remains uncertain according to current guidelines.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with ipsilateral locally recurrent breast cancer who previously underwent ipsilateral axillary surgery.
* Female patients aged 18 years or older.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
* Patients who voluntarily decide to participate in the study and provide written informed consent.

Exclusion Criteria:

* Patients with distant metastases.
* Patients who previously underwent ipsilateral mastectomy.
* Pregnant or breastfeeding women.
* Patients with a general condition that impairs the ability to understand or provide informed consent.

Where it's running

• National Cancer Center
  Goyang-si, South Korea Recruiting

Study contacts

• Principal investigator: Seeyoun Lee — National Cancer Center, Korea
• Study coordinator: Seeyoun Lee
• Phone: +82-31-920-1736

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using indocyanine green to find sentinel lymph nodes during mastectomy

  This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.

  Recruiting at 2 sites St. Antonius Hospital · Zwolle, Overijssel and 1 other locations · NCT07362485

• Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery

  This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.

  Recruiting at 7 sites St. Antonius Hospital · Alkmaar and 6 other locations · NCT07146295

• Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease

  This audit will test if removing the marked node along with the sentinel nodes can identify people with only 1–2 positive axillary nodes so some can avoid a full axillary dissection, for adults with cT1-2 breast cancer and biopsy-proven axillary metastases with no more than two abnormal nodes on imaging.

  Recruiting at 14 sites University Hospitals of Derby and Burton NHS Foundation Trust · Burnley and 13 other locations · NCT07085442

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.